Cotrimoxazole Prophylaxis in Transurethral Resection or Greenlight Laser Vaporisation of the Prostate
Status:
Recruiting
Trial end date:
2022-03-31
Target enrollment:
Participant gender:
Summary
The optimal duration of antimicrobial prophylaxis (study medication Cotrimoxazole
(Trimethoprim/Sulfamethoxazole)) in transurethral resection of the prostate and Greenlight
Laser vaporisation of the prostate is investigated by comparing a guideline-conform
single-dose prophylaxis (intervention) versus usual clinical care (i.e. 3-day prophylaxis;
control) for prevention of urinary tract infections.